CETP and metabolic dysfunction-associated steatohepatitis: A novel CETP vaccine (Fc-CETP6) efficiently elicited antibodies against CETP and reduced susceptibility to both AS and MASH induced by the HFHC diet via increasing plasma HDL-c and ApoA-I levels and decreasing plasma ox-LDL.